(102CT2018) a Multi-Center Phase II Study of AUY922 in Patients with Stage IV Advanced Non-Small Cell Lung Cancer with Driver Molecular Alterations Other Than Sensitive EGFR Mutation, Who Have Progressed after One Line of Systemic Therapy (II)

Project title

針對有主導性基因變異(敏感性表皮生長因子受體突變除外)的第四期非小細胞肺癌患者先前接受過一種全身性治療仍惡化，使用 AUY922的多中心的第二期試驗(II)

Internal ID

NSC103-2325-B002-017

Principal Investigator

Start Date

November 1, 2014

End Date

October 31, 2015

Organizations

Partner Organizations

National Science and Technology Council